NTLA vs PSX · rev $22.7M vs P/E 17, rev $83.54B
Intellia Therapeutics Inc (NTLA) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
Intellia Therapeutics Inc (NTLA) is a biotechnology company listed on US.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
Latest reported NTLA revenue for 2026-06-30 was $22.7M. Net income was -$202.9M. Revenue was up 50.9% from 2026-03-31 to 2026-06-30. NTLA currently screens at market cap $1.19B.
Latest reported PSX revenue for 2026-06-30 was $83.54B. Net income was $4.05B. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
NTLA currently screens at market cap $1.19B. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the NTLA and PSX stock pages for the full models.
Not investment advice.